Some evidence indicates medical marijuana may be useful to treat pain, but the workers’ comp system is not yet equipped to handle the issue on a large-scale basis.
The recent success of the closed pharmacy formulary in the Texas workers’ comp system shows promise for other states, especially in regions where non-formulary drugs are prevalent.
A New Mexico appeals court decision ordering an employer and insurer to reimburse an injured worker for his medical marijuana is believed to be the first such court ruling in the nation.
A growing number of physicians are turning to pharmacogenetics to evaluate how workers’ comp claimants will respond to prescription drugs based on a patient’s genetic makeup.